Literature DB >> 27059040

WHIM Syndrome Caused by Waldenström's Macroglobulinemia-Associated Mutation CXCR4 (L329fs).

Qian Liu1, Catherina Pan1, Lizbeeth Lopez1, Jiliang Gao1, Daniel Velez1, Sandra Anaya-O'Brien2, Jean Ulrick2, Patricia Littel2, John S Corns3, Donald T Ellenburg4, Harry L Malech2, Philip M Murphy1, David H McDermott5.   

Abstract

WHIM syndrome is an autosomal dominant immunodeficiency disease caused by mutations affecting the carboxy-terminus of CXCR4. To characterize novel genetic causes of the syndrome, we recruited a pediatric patient with possible WHIM syndrome, performed CXCR4 gene sequencing and compared his clinical phenotype and CXCR4 tail amino acid sequences with other patients with WHIM syndrome carrying CXCR4 (R334X) mutations. We identified and biochemically characterized a heterozygous 5 base pair deletion (nucleotides 986-990) located in the portion of the open reading frame (ORF) of CXCR4 that encodes the carboxy-terminal domain of the receptor. This CXCR4 (L329fs) mutation causes a frame-shift at codon 329 resulting in replacement of the final 24 predicted amino acids of the receptor with 12 missense amino acids. Like previously reported WHIM mutations, this frame-shift mutation CXCR4 (L329fs) decreased receptor downregulation in response to the CXCR4 agonist CXCL12 in patient PBMCs as well as in transfected K562 and HEK 293 cells, but increased calcium flux responses in K562 cells to CXCL12 stimulation. Thus, CXCR4 (L329fs) appears to be a de novo autosomal dominant frame-shift gain-of-function mutation that like other carboxy-terminus mutations causes WHIM syndrome. The same CXCR4 (L329fs) frame-shift variant has been reported to occur in tumor cells from a patient with Waldenström's Macroglobulemia (WM), but is caused by a distinct genetic mechanism: insertion of a single nucleotide in the L329 codon, providing additional evidence that the carboxy-terminus of CXCR4 is a genetic hotspot for mutation.

Entities:  

Keywords:  CXCR4; WHIM syndrome; gain of function; immunodeficiency; internalization; mutation

Mesh:

Substances:

Year:  2016        PMID: 27059040     DOI: 10.1007/s10875-016-0276-3

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  26 in total

Review 1.  A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia.

Authors:  M Wetzler; M Talpaz; E S Kleinerman; A King; Y O Huh; J U Gutterman; R Kurzrock
Journal:  Am J Med       Date:  1990-11       Impact factor: 4.965

2.  Distinct abnormalities in the innate immune system of children with Down syndrome.

Authors:  Beatrijs L P Bloemers; Grada M van Bleek; Jan L L Kimpen; Louis Bont
Journal:  J Pediatr       Date:  2010-02-20       Impact factor: 4.406

Review 3.  Regulation of CXCR4 signaling.

Authors:  John M Busillo; Jeffrey L Benovic
Journal:  Biochim Biophys Acta       Date:  2006-11-10

4.  Live imaging of neutrophil motility in a zebrafish model of WHIM syndrome.

Authors:  Kevin B Walters; Julie M Green; Jill C Surfus; Sa Kan Yoo; Anna Huttenlocher
Journal:  Blood       Date:  2010-06-30       Impact factor: 22.113

5.  Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients.

Authors:  Laura Tassone; Daniele Moratto; William Vermi; Maria De Francesco; Lucia D Notarangelo; Fulvio Porta; Vassilios Lougaris; Fabio Facchetti; Alessandro Plebani; Raffaele Badolato
Journal:  Blood       Date:  2010-08-24       Impact factor: 22.113

Review 6.  CXCR4 mutations in WHIM syndrome: a misguided immune system?

Authors:  George A Diaz
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

7.  Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia.

Authors:  Steven P Treon; Yang Cao; Lian Xu; Guang Yang; Xia Liu; Zachary R Hunter
Journal:  Blood       Date:  2014-02-19       Impact factor: 22.113

8.  Distinct mechanisms of agonist-induced endocytosis for human chemokine receptors CCR5 and CXCR4.

Authors:  Sundararajan Venkatesan; Jeremy J Rose; Robert Lodge; Philip M Murphy; John F Foley
Journal:  Mol Biol Cell       Date:  2003-05-03       Impact factor: 4.138

9.  AMD3100 is a potent antagonist at CXCR4(R334X) , a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome.

Authors:  David H McDermott; Joseph Lopez; Francis Deng; Qian Liu; Teresa Ojode; Haoqian Chen; Jean Ulrick; Nana Kwatemaa; Corin Kelly; Sandra Anaya-O'Brien; Mary Garofalo; Martha Marquesen; Dianne Hilligoss; Rosamma DeCastro; Harry L Malech; Philip M Murphy
Journal:  J Cell Mol Med       Date:  2011-10       Impact factor: 5.310

10.  Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry.

Authors:  Sarah Beaussant Cohen; Odile Fenneteau; Emmanuel Plouvier; Pierre-Simon Rohrlich; Gerard Daltroff; Isabelle Plantier; Alain Dupuy; Delphine Kerob; Blandine Beaupain; Pierre Bordigoni; Fanny Fouyssac; Anne-Lise Delezoide; Gilles Devouassoux; Jean François Nicolas; Philippe Bensaid; Yves Bertrand; Karl Balabanian; Christine Bellanne Chantelot; Françoise Bachelerie; Jean Donadieu
Journal:  Orphanet J Rare Dis       Date:  2012-09-25       Impact factor: 4.123

View more
  8 in total

Review 1.  Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3.

Authors:  Philip M Murphy; Lauren Heusinkveld
Journal:  Cytokine       Date:  2018-02-15       Impact factor: 3.861

Review 2.  It Takes Three Receptors to Raise a B Cell.

Authors:  Kaitlin C McLean; Malay Mandal
Journal:  Trends Immunol       Date:  2020-05-22       Impact factor: 16.687

Review 3.  WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure.

Authors:  Lauren E Heusinkveld; Shamik Majumdar; Ji-Liang Gao; David H McDermott; Philip M Murphy
Journal:  J Clin Immunol       Date:  2019-07-16       Impact factor: 8.317

Review 4.  Consideration of underlying immunodeficiency in refractory or recalcitrant warts: A review of the literature.

Authors:  J Zampella; B Cohen
Journal:  Skin Health Dis       Date:  2022-02-09

5.  Pathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency.

Authors:  Lauren E Heusinkveld; Erin Yim; Alexander Yang; Ari B Azani; Qian Liu; Ji-Liang Gao; David H McDermott; Philip M Murphy
Journal:  Expert Opin Orphan Drugs       Date:  2017-09-25       Impact factor: 0.694

6.  The negative charge of the 343 site is essential for maintaining physiological functions of CXCR4.

Authors:  Liqing Wang; Qiuhong Xiong; Ping Li; Guangxin Chen; Nayab Tariq; Changxin Wu
Journal:  BMC Mol Cell Biol       Date:  2021-01-23

7.  Mesenchymal Stem/Stromal Cells Overexpressing CXCR4R334X Revealed Enhanced Migration: A Lesson Learned from the Pathogenesis of WHIM Syndrome.

Authors:  Hamid Reza Bidkhori; Ahmad Reza Bahrami; Moein Farshchian; Asieh Heirani-Tabasi; Mahdi Mirahmadi; Halimeh Hasanzadeh; Naghmeh Ahmadiankia; Reza Faridhosseini; Mahtab Dastpak; Arezoo Gowhari Shabgah; Maryam M Matin
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

Review 8.  Aberrant CXCR4 Signaling at Crossroad of WHIM Syndrome and Waldenstrom's Macroglobulinemia.

Authors:  Samantha Milanesi; Massimo Locati; Elena Monica Borroni
Journal:  Int J Mol Sci       Date:  2020-08-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.